Low expression of IL-37 protein is correlated with high Oct4 protein expression in hepatocellular carcinoma
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Medical Science and Technology Foundation of Guangdong Province
- Natural Science Foundation of Guangdong Province
This publication has 23 references indexed in Scilit:
- Impact of interleukin-22 on K-ras mutant lung cancer promotion and stemness propertiesJournal of Thoracic Oncology, 2016
- TGF-βI Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in EndometriosisPLOS ONE, 2015
- Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcomeWorld Journal of Hepatology, 2015
- Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG ExpressionClinical Cancer Research, 2015
- Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK CellsScientific Reports, 2014
- IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activityJournal of Translational Medicine, 2014
- Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responsesProceedings of the National Academy of Sciences, 2014
- Interleukin‐37 reduces liver inflammatory injury via effects on hepatocytes and non‐parenchymal cellsJournal of Gastroenterology and Hepatology, 2012
- IL-37 is a fundamental inhibitor of innate immunityNature Immunology, 2010
- Recombinant adenovirus IL-24-Bax promotes apoptosis of hepatocellular carcinoma cells in vitro and in vivoCancer Gene Therapy, 2010